Jocelynn R. Pearl
Advanced Pharma(US)
Publications by Year
Research Areas
Genetic Neurodegenerative Diseases, CRISPR and Genetic Engineering, Bioinformatics and Genomic Networks, Epigenetics and DNA Methylation, CAR-T cell therapy research
Most-Cited Works
- → Translating dosage compensation to trisomy 21(2013)335 cited
- → De novo design of protein logic gates(2020)219 cited
- → Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease(2019)216 cited
- → Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease(2016)191 cited
- → Site-specific genome editing in Plasmodium falciparum using engineered zinc-finger nucleases(2012)167 cited
- → Transcriptional regulatory networks underlying gene expression changes in Huntington's disease(2018)87 cited
- → Genome-Scale Transcriptional Regulatory Network Models of Psychiatric and Neurodegenerative Disorders(2019)78 cited
- → High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington’s disease CAG knock-in mice across multiple genetic backgrounds(2017)49 cited
- → Activation domains for controlling plant gene expression using designed transcription factors(2013)46 cited
- → Enhanced retinal responses in Huntington’s disease patients(2017)16 cited